Locations
San Diego, CA, USA
industry
Biotechnology · DeepTech · Health · Manufacturing
Size
11-50 employees
Stage
Series A
founded in
2018
Prominex is moving forward with ambitions to develop a 5-minute SARS-CoV-2 test on their point-of-care molecular diagnostic platform. The company is dedicated to increasing access to low-cost, quick infectious disease diagnostics for STIs and respiratory illnesses. Our SARS-CoV-2 test provides accurate results in 5 minutes, allowing healthcare practitioners to make more informed treatment and infection management decisions. devoted to increasing access to low-cost, quick infectious disease tests for STIs and respiratory illnesses. Our SARS-CoV-2 test provides accurate results in 5 minutes, allowing healthcare practitioners to make more informed treatment and infection management decisions.
Something looks off?On-site & Remote